drugset / Trial / NCT06204419
A Phase I Study of XH-S002 in Healthy Volunteers
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of the study is to assess the safety, tolerability and pharmacokinetics of XH-S002 in healthy volunteers under SAD (Single ascending dose) and MAD (Multiple ascending dose) studies. In addition, this study evaluates the food effects of XH-S002.
Timeline
- Start
- 2023-12-26
- Primary completion
- 2024-07
- Completion
- 2024-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | XH-S002 | Unknown | — | Oral |
Indications
No indication recorded.